Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

DenmarkBack to Denmark

Clinical trials in Odense – page 42

515 clinical trials in Odense, Denmark across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Odense at a glance
515
clinical trials
  • Research sites4
Type of trial
Recruitment status
Quick filters

515 trials in Odense

Open in trial search

Oesophageal carcinoma

Not recruiting

Study on the Effectiveness and Safety of Pembrolizumab, Lenvatinib, and Chemotherapy for Patients with Metastatic Esophageal Cancer

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Merck Sharp & Dohme LLC

Endometrial cancer

Not recruiting

Study on GEN1046 and Pembrolizumab for Patients with Advanced Endometrial Cancer

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Genmab A/S

Transitional cell carcinoma

Not recruiting

Study on Reduced BCG Dwell-Time for Patients with High-Risk Urothelial Cancer

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Sponsor:Region Midtjylland

Acute coronary syndrome

Not recruiting

Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Janssen Cilag International

Endometrial cancer

Not recruiting

Study of Pembrolizumab with Chemotherapy for High-Risk Endometrial Cancer Patients After Surgery

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Merck Sharp & Dohme LLC

Triple negative breast cancer

Not recruiting

Study of RO7247669 and Nab-Paclitaxel vs. Pembrolizumab and Nab-Paclitaxel for Patients with Untreated, PD-L1 Positive, Advanced Triple-Negative Breast Cancer

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Sponsor:F. Hoffmann-La Roche AG

Squamous cell carcinoma of head and neck+1

Not recruiting

Study of IO102-IO103 and Pembrolizumab for Patients with Resectable Melanoma and Head and Neck Squamous Cell Carcinoma

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Io Biotech ApS

Renal cell carcinoma

Not recruiting

Study of Pembrolizumab, Belzutifan, and Lenvatinib for Patients with Advanced Clear Cell Renal Cell Carcinoma

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Belzutifan
  • Sponsor:Merck Sharp & Dohme LLC

Bronchiectasis

Not recruiting

Study on Long-Term Safety and Efficacy of BI 1291583 in Patients with Bronchiectasis

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:BI 1291583
  • Sponsor:Boehringer Ingelheim Espana S.A.

Microsatellite instability cancer+1

Not recruiting

Study Comparing MK-1308A and Pembrolizumab for Patients with Advanced Colorectal Cancer with High Microsatellite Instability or Mismatch Repair Deficiency

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:MK-4830
  • Sponsor:Merck Sharp & Dohme LLC

Renal cell carcinoma stage IV+1

Not recruiting

Study Comparing Nivolumab and Ipilimumab with Sunitinib for Patients with Advanced or Metastatic Kidney Cancer

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Ipilimumab
  • Sponsor:Bristol Myers Squibb International Corporation

Rectal cancer

Not recruiting

Study Comparing Neoadjuvant Chemotherapy with Capecitabine and Oxaliplatin to Standard Treatment for Patients with Locally Advanced Rectal Cancer

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Region Sjaelland

Other cities in Denmark

The busiest research cities in the country

All 45 cities in Denmark

Clinical research in Odense

What the registry says about research in the country

01 Respiratory and Pulmonary Research

Clinical investigations focusing on Idiopathic Pulmonary Fibrosis and chronic respiratory conditions. Studies evaluating new therapeutic approaches for managing nasal polyps and chronic rhinosinusitis.

  • Pulmonary Fibrosis Treatment
  • Nasal Polyps Management
  • Chronic Rhinosinusitis

Trials aim to assess innovative treatments and monitor long-term disease control.

02 Oncology Studies

Comprehensive research into various cancer types, including bladder cancer, metastatic breast cancer, and prostate cancer. Focus on innovative therapies and treatment combinations.

  • Cancer-Related Fatigue
  • Advanced Breast Cancer
  • Prostate Cancer Therapy

Studies evaluate novel treatment approaches and drug combinations for better patient outcomes.

03 Autoimmune and Inflammatory Conditions

Research focusing on Inflammatory Bowel Disease, including Crohn's Disease and Ulcerative Colitis. Studies of treatments for Sjögren's Syndrome and immune thrombocytopenia.

  • Gastrointestinal Disorders
  • Immune System Disorders
  • Chronic Inflammatory Conditions

Trials assess both established and experimental therapies for inflammatory conditions.

04 Cardiovascular and Renal Studies

Investigations into chronic kidney disease, heart conditions, and transplant outcomes. Research includes studies on aortic stenosis and myocardial infarction treatments.

  • Kidney Transplantation
  • Cardiac Conditions
  • Renal Disorders

Focus on improving treatment outcomes and patient care in cardiovascular and renal conditions.

Back to DenmarkAll countries
Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.